Patentee wins on marking statute interpretation but evidence shortcomings kill pre-suit damages anyway

In the ongoing patent battle between WiAV Solutions, LLC and a number of mobile technology companies (Motorola, Nokia, et al.), Judge Robert E. Payne has ruled in the last two days on two of defendants’ motions for summary judgment.  One opinion’s interpretation of the patent marking statute has implications beyond this suit, and that opinion also offers both positive and negative procedural lessons of which practitioners should take note.

The case is Eastern District of Virginia case no. 3:09-CV-447 (although it may also be designated as the “full employment for lawyers” case, with, by my count, 59 lawyers listed on the docket on PACER).  We have previously blogged about the dismissal of a number of WiAV’s other claims and their subsequent certification for appeal.  (That appeal can be followed on PACER as Federal Circuit case no. 2010-1266, with oral argument set for September 10.)

The ruling on marking

On June 10, Defendants moved for summary judgment of no willful infringement and of no-pre-suit damages.  The Court’s August 10 memorandum opinion granted summary judgment as to no pre-suit damages and accordingly denied the willful infringement aspect of the motion as moot.

The patent marking statute, 35 U.S.C. 287(a), “encourages” patentees and those making, selling, offering to sell, or importing a patented article to give notice of the patent by putting the patent number on the patented article.  The encouragement comes in the provision that “In the event of failure so to mark, no damages shall be recovered by the patentee in any action for infringement, except on proof that the infringer was notified of the infringement and continued to infringe thereafter, in which event damages may be recovered only for infringement occurring after such notice.

As part of its claim of infringement of U.S. Patent No. 6,539,205 (“Traffic channel quality estimation from a digital control channel”), WiAV sought pre-suit damages from July 14, 2003, through December 31, 2007.  WiAV did not seek pre-suit damages from December 31, 2007, to July 14, 2009 (when the suit was filed, thereby giving actual notice of infringement) because it was undisputed that several major companies (LG, RIM, Apple, and HTC) acquired licenses and sold unmarked articles on various dates beginning on December 31, 2007.

WiAV argued that sales by two other companies (Mindspeed and Skyworks) prior to December 31, 2007, did not trigger the statutory requirement to mark and therefore that the failure to mark did not bar pre-suit damages for the 2003-07 period.

Defendants asserted that, under the plain language of the statute, no damages can be recovered until actual notice is given, even damages that accrue before a requirement to mark is triggered.  They argued that WiAV wanted to revise the statute through construction to read that “no damages shall be recovered by the patentee in any action for infringement during the period in which there is a failure to mark, except on proof...”

The Court held that Defendants "ignore[d] the statutory context in which the provision precluding damages appears" and that "the statute gives rise to some ambiguity" on the period for which damages are precluded.  (Mem. Op. at 11.)  The parties then disagreed as to how the ambiguity should be resolved in light of the purposes of the statute.

The Federal Circuit described three purposes of the statute in Nike, Inc. v. Wal-Mart Stores, Inc., 138 F.3d 1437, 1443 (Fed. Cir. 1998): (1) helping to avoid innocent infringement, (2) encouraging patentees to give notice to the public that the article is patented, and (3) aiding the public to identify whether an article is patented. 

In 2003, the District of Delaware ruled favorable to WiAV’s argument, holding that a patentee can recover damages for infringement during a period of time when § 287 is not triggered, even if § 287 is later triggered and the patentee fails to comply.  The Court reached that result after concluding that “it is only when the patentee is himself contributing to the problem of innocent infringement by producing unmarked product that 287(a) punishes that patentee by precluding damage recovery.”  (Mem. Op. at 12.)

The defendants argued here, however, that allowing division of damages periods as WiAV sought would render the statute ineffective at achieving its "principal purpose" of providing notice. 

The Court concluded that Defendants' interpretation "penalizes the patentee for failing to comply with a statute that the patentee was not required to comply with in the first place.  And it is simply unreasonable to read the statute in this manner."  Therefore, the Court held "that a patentee is not precluded from collecting damages for a period in which marking was not required even if the requirements of the marking statute were later triggered and the patentee failed to comply."  (Mem. Op. at 13.)

Procedure dooms WiAV's pre-suit damages anyway

WiAV’s statutory interpretation victory was short-lived, however.  The Court rejected WiAV’s attempt to shift the burden to the defendants to prove that the marking statute was applicable.  Rather, citing an 1894 Supreme Court opinion, the Court held that it was "clear that the patentee bears the burden of showing compliance with the marking statute."  (Mem. Op. at 14.)  WiAV failed to survive summary judgment because it failed to offer evidence that could lead a jury to find in its favor on that point, on which it bore the burden of proof.

WiAV relied on 30(b)(6) testimony to show that one pre-Dec. 31, 2007 company (Mindspeed) was not practicing the patent (and thus that the marking statute was not triggered).  Unfortunately for WiAV, however, the deponent contradicted that statement twice later in the deposition. 

Expert testimony was needed, said the Court, to draw any conclusion about whether pre-Dec. 31, 2007 sales practiced the patent, and WiAV failed to offer such evidence.  WiAV did offer a declaration of its expert, but the Court held that, even if allowed, that declaration was “entirely speculative and conclusory” and thus wholly failed to explain the technical details necessary to accept WiAV’s arguments that pre-Dec. 31, 2007 sales did not practice the patent.

The Court also ruled against WiAV with respect to the other company (Skyworks) that was involved prior to Dec. 31, 2007, holding that offers to sale counted as practicing the patent and also that WiAV failed to offer evidence to prove that Skyworks made no sales or offers for sale in the United States.  Again, WiAV relied on a 30(b)(6) deponent who contradicted himself twice later, and again that was insufficient because WiAV bore the burden.

The summary judgment procedural lessons are clear:  A party must understand all of the issues on which it bears the burden of proof and support those issues with evidence.  A litigant cannot count on 30(b)(6) testimony if that testimony is not clear, and experts must go beyond mere conclusions to provide grounds for a fact finder to adopt their conclusions.  Furthermore, as my colleagues have recently emphasized and as this blog regularly observes, the Eastern District’s “Rocket Docket” places special constraints on presentation of evidence, including requiring litigants to be organized from the very beginning and often greatly constraining the time available to search for and prepare to present such evidence.

Defendants skillfully navigate the Local Rules

Eastern District practitioners may have wondered if there was a misprint in the first paragraph of this blog entry, which refers to defendants’ motions for summary judgment, plural. 

Local Civil Rule 56(C) prohibits separate motions for summary judgment on separate grounds without leave of court.  As I’ve noted in a past blog entry, in conjunction with the Local Rules’ page limits on briefs, that limits what can be raised at summary judgment and is a significant part of how the Eastern District’s “Rocket Docket” avoids flurries of motions and forces litigants to move things along toward trial.

In this case, however, defendants successfully moved the Court to allow them to file three motions for summary judgment, divided by issue.  They were, no doubt, aided in that effort by the ability to argue that doing so was actually more efficient than having multiple defendants raise several issues in overlapping presentations, such that they were not seeking an increase in the number of possible motions or the number of pages overall.

This example shows that Eastern District judges will listen to reason with respect to the Local Rules, but litigants need to conceptualize how their case should be presented and must ask the Court for appropriate procedural relief where necessary.

 

NTP Goes Big Game Hunting Again

Yesterday, July 8th, Virginia patent company NTP, Inc. filed suit in the Richmond Division of the Eastern District of Virginia against pretty much every mobile technology heavyweight it had not yet sued, namely:  Apple, Google, HTC, LG, Microsoft, and Motorola.

The case numbers and complaints are listed here:

The cases allege infringement of eight patents related to e-mail and mobile devices (collectively, “the Campana Patents”).  That designation refers to Thomas Campana, who the Complaints allege invented wireless e-mail.

Five of the patents at issue were the subject of NTP’s high-stakes patent litigation war against RIM, the makers of Blackberry devices (E.D. Va. case no. 3:01-CV-767).  All of the new cases have been assigned to Chief Judge James R. Spencer, before whom NTP prevailed against RIM.  These too should draw significant media coverage.

Keep in mind that NTP also has additional suits, filed in 2006 and 2007, that are pending in the Eastern District of Virginia against Palm, T-Mobile, Verizon Wireless, AT&T, Sprint Nextel, and Alltel.  Seven of the patents involved in NTP's new suits are also at issue in its action against Palm, and all eight are at issue in the suits against the others.  Those cases are stayed pending reexamination, and as we’ve blogged before, NTP has not fared so well before the PTO (although one would not know that from the Complaints).

NTP is represented by Christian & Barton and (in at least some of the cases) by Goodwin Procter LLP and Hughes, Hubbard & Reed LLP.

 

E.D. Va. in Top 5 for Speed, Patentee Favorability

We blogged earlier about Prof. Mark Lemley's conclusions that the Eastern District of Virginia was a top venue for patentee plaintiffs (and for fastest resolution).  Another patent litigation report -- this time by LegalMetric, an intellectual property case law research and analysis company -- has now come to similar conclusions. 

The exact rankings appear to differ a bit, and LegalMetric's full data/methodology is not explained online (although we gathered and reported a bit of information about LegalMetric's methodology in a prior post).  The company recently ranked the Eastern District of Virginia among the top five districts in two categories:

  • Most Favorable to Patentee based on last ten years contested judgments for districts with at least 30 contested judgments, and

  • Fastest based on last ten years of contested judgments for districts with at least 30 contested judgments.

The latter speed ranking comes as no surprise in the "Rocket Docket," but the continued ranking of the Eastern District among top patentee plaintiff venues may raise some eyebrows.

The Jamie Foxx deception, the unquestionably accurate New York Times, and more from the "Dreamgirls" case

“Dreamgirls” fans and entertainment execs, breathe easy.  On Monday, Chief U.S. District Judge James R. Spencer granted a motion to dismiss a case brought by a pro se litigant alleging that the film infringed upon his copyright.  In Bailey v. Black Entertainment Television, Inc. et al (Eastern District of Virginia case no. 3:09-cv-00787), Plaintiff James R. Bailey sued BET, Paramount, and Viacom, asserting that the 2006 film infringed upon a screenplay he had written in 1992 named “Poison Passion.”

Bailey apparently has a copyright infringement claim history.  Defendants pointed out that he had previously claimed that the film “The Negotiator” infringed upon his work.  See Bailey v. New Regency Prods., Inc., No. 99-2525, 2000 WL 338993 (4th Cir. Mar. 31, 2000) (unpublished).  And Bailey alleged in his Complaint that the defendants had previously committed copyright infringement by using his screenplay “Topless Burning Love” to make the movie “Boomerang.”

In this Complaint about “Dreamgirls,” Bailey claimed that several of the film’s central characters (James Early, played by Eddie Murphy; Deena, played by Beyonce Knowles; and Effi, played by Jennifer Hudson) were “exact replica[s]” of characters in his work.

Defendants responded by moving to dismiss under Rule 12(b)(6) and the “Twiqbal” standard.  In their memorandum, they pointed to the 1981 Tony Award-winning Broadway play by the same name, “from which the film was adapted and which featured these very same characters with these very same names and occupations.”  They also asserted that Bailey had failed to allege the elements required when verbatim duplication is not claimed – specifically, that the defendant had access to the copyrighted work and that the defendant’s work is “substantially similar” to the protected material.

In a response titled "Motions for Constitutional and Technically Evidential Opposition to Defendants' Motions to Dismiss Case," Bailey (who “is a Historian as well as a Screenwriter” and also wrote a sci-fi novel about the Cold War) gave an interesting discourse on Hollywood depictions of Cleopatra.  He also noted that “Defendants tried to be deceptive by having actor Jamie Foxx play the characterization of 'Poison Passion's' Dominique Prince.”  And he closed on an ominous note:  “If this case is not resolved in Court ... [it] will be resolved in the Power and Law of Fate.  And whomever deserves punishment for their unlawful action(s) will in all due likelihood receive it accordingly.”

In his May 3rd Memorandum Opinion, Judge Spencer agreed that the Complaint failed to allege any access by the Defendants to Bailey’s work prior to the year 2000. 

In addition, pursuant to Fed. R. Evid. 201(b), which allows judicial notice of facts that are "capable of accurate and ready determination by resort to sources whose accuracy cannot reasonably be questioned," Judge Spencer took judicial notice of a December 21, 1981, New York Times article submitted by Defendants and regarding the Broadway production.  Because “Bailey has not presented any evidence to rebut Defendants' assertion that the characters and storyline of the 2006 film ‘Dreamgirls’ that he accuses of infringement were the same characters created for the Broadway musical ‘Dreamgirls’ in 1981, eleven years before Mr. Bailey copyrighted his screenplay,” Judge Spencer held that the Complaint failed to state a plausible claim.

Bailey has 30 days to appeal.

Eastern District of Virginia -- A Top Venue for Patentee Plaintiffs (?)

As reported on Dennis Crouch’s Patently-O (link here), Professor Mark A. Lemley of Stanford Law School has released a draft of his study on patent forum shopping, “Where to File Your Patent Case” (found here). The U.S. District Court for the Eastern District of Virginia gets a fair amount of attention in Professor Lemley’s study. Some of the take-away points about the Eastern District of Virginia include:

  • The Eastern District Virginia is the second “best aggregate district for plaintiffs,” after the Middle District of Florida, and ranks at the top of surveys based on outcome-oriented plaintiffs and plaintiffs’ interest in getting to trial.
  • The Eastern District of Virginia has an patentee “win rate” is a relatively high 30.4% -- not far off of the Eastern District of Texas (at 40.3%) and above the traditionally plaintiff-friendly Western District of Wisconsin (at 24.0%);
     
  • The Eastern District of Virginia has the fourth highest rate of patent cases going to trial (at 6.4%), just below the District of Delaware (11.8%), Eastern District of Texas (8.0%), and Western District of Wisconsin (7.4%);
  • The Eastern District of Virginia has the second shortest time to resolution (0.64 years) and time to trial (0.96 years), just shy of the Western District of Wisconsin (0.56 and 0.67, respectively);

Thus, if statistics are any guide, the Eastern District of Virginia appears to be one of the best venues for patentee plaintiffs. 

 

The results of Professor Lemley’s study are interesting. For example, he points out that the W.D. of Wisconsin, usually a top choice for plaintiffs, actually has among the lowest patentee win rates. Likewise, the Eastern District of Texas is not one of the five best districts for plaintiffs. While Professor Lemley includes a number of caveats and qualifications, his draft report (and Dennis Crouch’s summary thereof) are well worth a read.

Word to the Wise: Enforce Your Patents Before They're Rejected

On Friday, the Board of Patent Appeals and Interferences rejected yet another of NTP’s patents, signaling further trouble for NTP’s pending patent lawsuits. 

Those who keep tabs on Virginia IP litigation know NTP as an active patent litigant who brought a high-profile patent infringement case against Research in Motion (RIM), makers of the popular Blackberry PDAs, in the United States District Court for the Eastern District of Virginia (case number 01-cv-00767). 

 

During the pendency of the litigation, the U.S. PTO began reexamination of five NTP patents, all of which relate to e-mail for mobile devices and all of which were at issue in the RIM suit. (Reexamination is a process where a person can have a patent reexamined by a patent examiner to verify a patent’s validity. To have a patent reexamined, a party must submit prior art that raises a “substantial new question of patentability.” See 35 U.S.C §§ 303 & 304.) 

 

RIM sought a stay in the litigation two months after the jury verdict in NTP’s favor, but reexamination came too late for RIM. Chief Judge James R. Spencer entered final judgment and ordered a permanent injunction, although he did stay the injunction pending appeal. See Final Order (entered August 5, 2003), available at 2003 U.S. Dist. LEXIS 26837. After a remand on RIM’s appeal, and with the threat of an injunction separating millions from their “Crackberrys,” NTP scored a $612.5 million settlement from RIM in March 2006.

 

Subsequently, NTP sued Palm, Inc. and AT&T Mobility LLC for patent infringement. Those cases are pending in the Eastern District (case numbers 06-cv-00836 and 07-cv-00550, respectively) but were stayed while reexamination proceedings were pending.

 

On November 10, the Board upheld the rejection of three of NTP’s patents, and Friday’s announcement spelled doom for a fourth. One patent remains before the Board on appeal. According to a Law360 article, NTP’s attorneys promise an appeal to the Federal Circuit.

 

Friday’s announcement reinforces that reexamination can be a decisive second-front in a patent litigation war. As the NTP litigation shows, however, the timing of reexamination can make all the difference.

Venue in the Eastern District of Texas (Updated)

Since I posted here on the shift of patent infringement case filings away from the Eastern District of Texas, the Federal Circuit has issued another decision reversing a denial of a motion to transfer venue in a patent case in the Eastern District of Texas (EDTex).  See In re Genentech, Misc. Dock. No. 901, 2009 U.S. App. LEXIS 10882 (Fed. Cir. May 22, 2009).

Genentech rejects several grounds cited in recent EDTex decisions denying transfer.

  • First, the Court rejected the rationale that the location of witnesses favors transfer only if transfer is more convenient for all witnesses. Many post-TS Tech decisions in the EDTex have routinely rejected transfer if the plaintiff could identify relevant witnesses who lived far away from both Texas and the transferee forum.

In Genentech, fourteen witnesses lived in California, the proposed transferee forum, while the six inventors lived in Europe, a prior art witness lived in Iowa and four of the patent prosecuting attorneys lived on the East Coast. The Federal Circuit held that the District Court had placed too much emphasis on the additional distance that the European witnesses would have to travel to go to California rather than Texas.

Thus, the Court soundly rejected the rationale that “Texas must be more convenient because it’s in the middle of the country” found in several EDTex decisions. Rather, where material witnesses reside in the transferee forum and no witnesses reside in the EDTex, it is clear error to find that the convenience of witnesses weighs against transfer.

  • The Federal Circuit also faulted the EDTex for requiring a showing that the witnesses in the transferee forum were “key witnesses.” Since they had relevant information, “it was not necessary for the district court to evaluate the significance of the identified witnesses’ testimony.”

Two other holdings in Genentech will also weigh in favor of transfer in future cases.

  • First, despite the storage of most documents electronically, the Court found that it was clear error to discount the burden to transport documents from California to Texas.
     
  • Second, the Court held that it was clear error to consider Genentech’s filing of an unrelated patent infringement suit in Texas in the decision to deny transfer.

One common basis for denying transfer post–TS Tech remains available – the presence of multiple defendants in different forums. In Genentech, both defendants were located in California (though they were in two different court districts). Where defendants are in multiple forums, or where there are relevant defense witnesses in multiple forums, transfer will remain difficult in the EDTex.
 

Eastern District of Virginia Court overturns USPTO denial of Patent Term Extension

A recent ruling in a Federal District Court in the Eastern District of Virginia could make patent term extensions available to many more patented pharmaceuticals. 

First a little background: Generally, a patent issuing from the USPTO is given an enforceable term that begins on issuance of the patent and ends twenty years from the filing date of the patent. In some cases, however, the United States Patent and Trademark Office (“USPTO”) may grant an extension to the normal patent term ("Patent Term Extensions") for patents claiming pharmaceuticals.  The Patent Terms Extensions may be granted to compensate for delays occurring during the approval process of the Food and Drug Administration. For successful pharmaceuticals, each day of patent term is extremely valuable and this approval process may consume a significant portion of the valuable patent term. To compensate for government delay, the patent term extension statute, 35 U.S.C. § 156(a)(5)(A), allows the patent owner to recapture some of the economic benefit or their patent term lost during the approval process. A patent term may be extended for a patent claiming a pharmaceutical if permission for the commercial marketing or use of the “product” is the first permitted commercial marketing or use of the “product” under the provision of law causing the delay. In PhotoCure, the ED VA had to consider what the term "product" means in the statute.

PhotoCure ASA patented (U.S. Patent No. 6,037,267) and applied for FDA approval of methyl aminolevulinate hydrochloride (“MAL hydrochloride”) for the treatment of actinic keratosis, a pre-cancerous skin lesion. After issuance, PhotoCure applied for a patent term extension in the USPTO to compensate for term "lost" during its FDA approval process, but the patent term extension was denied. In reaching their decision, the USPTO interpreted the term “product” in 35 U.S.C. § 156(a)(5)(A) to mean an “active moiety.” An “active moiety” is considered by the USPTO to be a portion of a compound that is responsible for its pharmacological activity. The USPTO cited the commercial marketing for a different compound with the same “active moiety,” aminolevulinic acid ("ALA"), as the first permitted commercial marketing of the "product," MAL hydrochloride. The chemical structures or ALA and MAL hydrochloride are below:

             

                                 ALA                                                         MAL hydrochloride

Though the compounds are not identical they are similar, the USPTO decided that MAL hydrochloride has the same “active moiety” as previously marketed ALA and is, therefore, not elgible for a patent term extension.

PhotoCure sued the USPTO in the Eastern District of Virginia. In its decision, the ED VA boldly struck down the USPTO interpretation of “product” as meaning merely an “active moiety. The ED VA held that sharing an active moiety should not be the test for whether “product” has already be permitted to be commercially marketed. The court held that by using the term "product" the statute requires a comparison of the entire “active ingredient." The court held that the compounds were structurally different and, therefore, different “products” under the law. The court further stated that the USPTO’s decision to deny a PTE based merely on an "active moiety" was “arbitrary, capricious, an abuse of discretion, or otherwise not in accordance with the law” under the Administrative Procedure Act. It is expected that the USPTO will appeal the case to the Federal Circuit to provide clarity in this important issue to the patent bar and the pharmaceutical industry.

What Patent Reform Means for Virginia

On April 2, the Senate Judiciary Committee passed a compromise version of S. 515, the Patent Reform Act (the “Act”). The original bill can be found here, and the amended bill is here.  A few observations on the Act’s impact on litigation in Virginia:

Venue

The original bill limited venue in most patent cases to districts where the defendant is incorporated, has its principal place of business or has a “regular and established physical facility . . . that constitutes a substantial portion of [its] operations.” This provision would have shifted cases from popular plaintiff’s forums like the Eastern District of Texas to the homes of high-tech companies such as California, Delaware and New Jersey/New York and perhaps Virginia, based on the high-tech presence in Northern Virginia.

The amended bill replaced those venue provisions with a very short new subsection, 28 U.S.C. §1400(c), which provides that “for the convenience of the parties and witnesses, in the interest of justice,” a district court shall transfer a patent case “upon a showing that the transferee venue is "clearly more convenient” than the current venue. (emphasis added).

The “clearly more convenient” language comes from In re Volkswagen, 545 F.3d 304, 315 (5th Cir. 2008) (en banc) and In re TS Tech, 551 F.3d 1315 (Fed. Cir. 2008). Some commentators have characterized the amendments as “codifying” TS Tech, but the true impact is likely to be more muddled. Since the Act does not alter 28 U.S.C. § 1404(a), courts may well continue to apply their existing venue transfer standards and ignore the “clearly more convenient” standard. More likely, courts will simply add the “clearly more convenient” standard to their existing analysis.

In Virginia, a “clearly more convenient” standard may produce fewer venue transfers. In several post-TS Tech decisions, transfer has been denied as not “clearly more convenient” where parties, evidence or witnesses are located in several forums. See Novartis Vaccines & Diagnostics, Inc. v. Hoffman LaRoche, Inc., 2009 U.S. Dist. LEXIS 14656 (E.D. Tex. Feb. 3, 2009) (transfer denied where drug developed in North Carolina, manufactured in Colorado, processed in Michigan or Switzerland, packaged in New Jersey and sold nationwide). Under Virginia federal court precedent, by contrast, transfer is often granted if the parties are not located in Virginia and Virginia is not the “center of accused activity.” See GTE Wireless v. Qualcomm, 71 F.Supp. 2d 517, 519 (E.D.Va. 1999). Thus, a “clearly more convenient” standard may shift the focus from whether the case has ties to Virginia to whether the case has ties to a particular transferee district. That accused activity is occurring nationwide, for instance, would count against transfer rather than, as it presently does, in favor of transfer.

District Court Pilot Program

The amended bill establishes a 10-year pilot program for patent cases in at least six U.S. District Courts. Courts included in the program must be among the 15 districts with the largest number of patent cases or that have adopted local patent rules. At least three of the courts must have more than 10 active judges (including three judges who have requested and been designated to hear patent cases), and at least three must have fewer than 10 active judges (including two designated patent judges). The pilot program includes $5 million a year for education of judges and hiring patent law clerks. Cases would still be randomly assigned to all judges, but non-patent judges could decline to accept patent cases.

Venue for Patent and Trademark Appeals

• A technical amendment in the Act moves venue for civil actions appealing various decisions of the PTO, BPAI and TTAB from the District Court in Washington, D.C. to the Eastern District of Virginia. Such actions include civil actions appealing decisions by the BPAI relating to patent rejections (35 USC 145) and interferences (35 USC 146), civil actions appealing decisions by the PTO relating to patent term adjustments (35 USC 154(b)(4)(A)), civil actions appealing decisions of the TTAB relating to registration of a trademark (15 USC 1071(b)(4)), and civil actions appealing suspensions or exclusions from practice before the PTO (35 USC 32). Though such actions are relatively rare, this change could increase the volume of patent practice in Virginia.

Patent Filings Shifting Away from the Eastern District of Texas

The Eastern District of Texas led the country in patent case filings in 2008 with 306, more than 100 cases more than the next two districts (the Central District of California with 198 and the Northern District of California with 171).

In two recent cases, though, the Fifth Circuit and the Federal Circuit overturned rulings from the Eastern District of Texas denying motions to transfer venue. In the Federal Circuit case, In re: TS Tech USA Corp., 551 F. 3d 1315 (Fed. Cir. 2008), decided on December 29, the Court held that the district judge had committed a “clear abuse of discretion” in refusing to transfer a case to Ohio when the relevant evidence and witnesses were located in Ohio, Michigan and Canada.

In the three months since TS Tech was decided, there have been 9 rulings on motions to transfer venue from the Eastern District of Texas. Five of those motions have been granted and four have been denied. Transfer has been denied where the relevant evidence or witnesses was not confined to a specific forum or region but are located around the country or in other countries, even if the case has no strong connection to Texas. Transfer has been granted where most of the parties, witnesses or evidence are located in one particular forum or where the plaintiff or the inventors are located outside of Texas.

Tellingly, since TS Tech, patent case filings in the Eastern District of Texas appear to be plummeting. So far in 2009, the Eastern District of Texas has fallen into fourth place, behind the Central District of California, the Northern District of California and the District of New Jersey. On average, filings in the Eastern District of Texas appear down approximately 40% off last year’s rate, while filings in the next three most popular districts appear on pace with last year. See Stanford IP Litigation Clearinghouse (registration required).

Here in Virginia, patent case filings are in line with average filings in 2008. The drop in filings in Texas, though, could mean that the Eastern District of Virginia, with its fast docket and the presence of a number of high technology companies in the district, may become even more popular for patent case filings.

Does the Eastern District of Virginia Need Local Patent Rules?

In recent years, federal district courts around the country have enacted local rules governing patent cases. The  Northern District of California was one of the first, and its local rules are now extensive and detailed. The Eastern District of Texas enacted local rules to speed up the litigation of patent cases, and it is now  the most popular forums for the litigation of patent suits in the country. The volume of patent cases, however, has slowed the E.D. Texas docket considerably.  Other districts have followed suit, including the Western District of Pennsylvania and, most recently, the District of Massachusetts, adopting local rules for patent cases. At least one result (and perhaps an underlying purpose) of those rules has been to encourage the filing of patent cases in those districts.

The Eastern District of Virginia is the original “Rocket Docket” having enacted local rules to speed up cases almost forty years ago. The E.D.Va. continues to be one of the fastest courts in the United States, with an average time to resolution of civil cases of only about six months. The E.D. Va. has also been a relatively popular forum for patent cases, ranking in the top ten of federal district courts for filing patent suits.

The E.D.Va., however, has no local rules for patent cases. Rather, the three divisions of the court, and even judges in the same division, follow different procedures for dealing with their cases and different ways of handling patent cases.  As a result, there is little predictability in the E.D.Va. on issues such as whether tol extend the pre-trial period for patent cases to allow for the greater amount of preparation necessary in such cases, whether the Court will allot more trial days for a patent trial than the two or maybe three days it allows for most trials and whether the Court will incorporate patent-specific procedures, such as the filing of claim charts and the scheduling of a Markman hearing.

There are many potential benefits to adoption of local patent rules. Scheduling can be more uniform, and the litigation can be streamlined. Conducting claim construction early in the case can remove uncertainty and encourage earlier resolution of cases, decreasing the Court’s workload. Given the volume of patent cases filed in the E.D.Va., the Court should consider adopting limited local rules addressing the unique features of patent litigation. Such rules should be simple, and they should be permissive, so that individual judges can adapt them to each judge's docket and the needs of a specific case.